Stevens Capital Management LP Ionis Pharmaceuticals Inc Transaction History

Stevens Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$59.06 - $72.15 $516,302 - $630,735	-8,742 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$62.09 - $86.14 $542,790 - $753,035	8,742 New	8,742 $562,000
Q3 2018 Nov 13, 2018	SELL	$42.88 - $53.7 $2.04 Million - $2.56 Million	-47,586 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$40.53 - $50.7 $837,390 - $1.05 Million	20,661 Added 76.74%	47,586 $1.98 Million
Q1 2018 May 08, 2018	BUY	$44.08 - $55.05 $1.19 Million - $1.48 Million	26,925 New	26,925 $1.19 Million
Q4 2017 Feb 13, 2018	SELL	$50.3 - $64.39 $661,495 - $846,792	-13,151 Closed	0 $0
Q3 2017 Nov 01, 2017	BUY	$45.56 - $59.57 $599,159 - $783,405	13,151	13,151 $667,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.